REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG)

Completed · Not applicable

Conditions studied: Stroke, Gait Disorders, Neurologic

In brief

The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment. REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical routine. The reference method for performance comparison will be motion capture.

Key facts

Study ID

NCT06234878

Run by

REEV LLC

People needed

23

Starts

2024-01-08

Expected to finish

2025-04-01

Last updated by the study team

2025-04-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Post-stroke gait disorder.
• Must be able to walk independently with or without the support of a cane or rollator.
• History of stroke more than six months ago.
• Be 18 years of age or older.

You may not qualify if…

• Subject unable to give consent.
• Subject unable to understand the tests.

Where it is running

• MIT Center for Clinical and Translational Research — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.